Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note issued to investors on Tuesday. The firm issued a buy rating on the stock. Trinity Biotech Stock Performance Shares of NASDAQ TRIB opened at $0.43 on Tuesday. The company has a market capitalization of $16.35 million, a P/E ratio […]

Leave a Reply

Your email address will not be published.

Previous post How far off are the Chicago Bears in the NFC North? Brad Biggs’ 10 thoughts after the Week 16 win on Christmas Eve.
Next post RayzeBio (NASDAQ:RYZB) Downgraded to “Market Perform” at William Blair